DI CESARE, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 1.083
EU - Europa 1.031
AS - Asia 198
OC - Oceania 3
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.317
Nazione #
US - Stati Uniti d'America 1.079
IE - Irlanda 324
SE - Svezia 309
CN - Cina 175
UA - Ucraina 102
DE - Germania 95
GB - Regno Unito 67
FI - Finlandia 49
IT - Italia 33
FR - Francia 27
IN - India 19
AT - Austria 12
BE - Belgio 10
CA - Canada 4
IR - Iran 4
NZ - Nuova Zelanda 2
RU - Federazione Russa 2
AU - Australia 1
BG - Bulgaria 1
EU - Europa 1
ZA - Sudafrica 1
Totale 2.317
Città #
Dublin 324
Chandler 210
Jacksonville 201
Nyköping 168
Beijing 90
Ashburn 69
Cambridge 48
Princeton 48
Lancaster 46
New York 40
Des Moines 38
Medford 36
Boardman 25
Dearborn 22
Ann Arbor 21
Wilmington 18
Bremen 17
Woodbridge 17
Messina 13
Pune 13
San Mateo 13
Vienna 12
Shenyang 10
Brussels 9
Nanjing 9
Jinan 8
Changsha 7
Hangzhou 7
Ningbo 7
Augusta 6
Hebei 5
Leawood 5
Falls Church 4
Taizhou 4
Washington 4
Zhengzhou 4
Auburn Hills 3
Guangzhou 3
Haikou 3
Mumbai 3
Nanchang 3
Rome 3
Ardabil 2
Auckland 2
Houston 2
Impruneta 2
Los Angeles 2
Norwalk 2
Ottawa 2
Palermo 2
San Benedetto del Tronto 2
Tianjin 2
Toronto 2
Altopascio 1
Andover 1
Antwerp 1
Boston 1
Chicago 1
Clayton 1
Clearwater 1
Cupertino 1
Gragnano 1
Helsinki 1
Huntsville 1
Jiaxing 1
Johannesburg 1
Lanzhou 1
London 1
Milan 1
Nashville 1
Novokuznetsk 1
Redmond 1
Seattle 1
Sofia 1
Strasbourg 1
Taiyuan 1
Vimercate 1
Xiangfen 1
Totale 1.643
Nome #
CORRELATION BETWEEN URINARY ACTIVITY OF N-ACETYL-B-D-GLUCOSAMINIDASE (NAG) AND ALBUMIN EXCRETION RATE IN TYPE II (NON INSULIN-DEPENDENT) DIABETICS SUBJECTS. 85
Reattività cutanea specifica con metodologia tradizionale e teletermografica dinamica computerizzata (TTDC) in corso di T.I.S. 78
E rosette formation in B cell chronic lymphocytic leukemia. 72
Aspetti emoreologici ed emocoagulativi in corso di trattamento con buflomedil cloridrato 67
Anticorpi anti P-53 in pazienti con diabete mellito di tipo 1 66
Autoantibodies against cytokeratin 19 in patients with type 1 diabetes mellitus 63
ARA-C a basse dosi nelle sindrome mielodisplastiche in differenti stati evolutivi 63
Anti-p53 autoantibodies in patients with IDDM 62
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 61
Serum anti-p53 autoantibodies in patients with type 1 diabetes 60
Age and metabolic control influence lens opacity in type I, insulin-dependent diabetic patients 60
Increased c-met expression during ductal beta cell neogenesis in experimental autoimmune diabetes 57
Beta 2 microglobulina ed emopatie maligne 57
PREVALENCE OF AUTOANTIBODIES TO CARBONIC ANHYDRASE II AND LACTOFERRIN IN PATIENTS WITH TYPE 1 DIABETES 55
Skin lesions in diabetes mellitus: prevalence and clinical correlations. 55
Correlates of total homocysteine plasma concentration in type 2 diabetes 53
La proteina C reattiva in una popolazione ad alto rischio di insorgenza del diabete mellito di tipo 2 52
L’ETA’ E IL COMPENSO METABOLICO CONDIZIONANO UNA PRECOCE OPACIZZAZIONE DEL CRISTALLINO NEL DIABETE MELLITO INSULINO-DIPENDENTE 52
Gastric mucosal mast cells in atopic subjects. 49
The influence of hypercholesterolemia on some aspects of immune pattern in the elderly. 49
Increased CXCL9/MIG serum Levels in young patients with type 1 diabetes 48
Le complicanze tardive del diabete mellito 47
[Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics]. 47
[Blood levels of glucagon, insulin and nonesterified fatty acids after arginine stimulation in obese patients]. 46
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective study 45
IL DIABETE MELLITO ASSOCIATO ALLA FIBROSI CISTICA: DATI GENETICI E CLINICO-METABOLICI DA UN FOLLOW-UP DECENNALE 45
Iperomocisteinemia moderata, polimorfismo MTHFR C677T e rischio di complicanze croniche nel diabete di tipo 2: uno studio prospettico 45
Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. 45
Effetti di uno stress fisico sulla funzione pistrinica e su alcuni parametri emocoagulativi e della fibrinolisi 45
Distributione anormale des T lymphocites dans la lymphangectasie intestinale primitive 44
Il diabete mellito quale fattore di rischio vascolare ed il possibile ruolo patogenetico dell'insulina 44
DIFFERENT DAILY BLOOD GLUCOSE CONTROL AND FREE INSULIN LEVELS DURING TREATMENT WITH MIXTURES OF SOLUBLE AND LENTE OR SOLUBLE AND NPH SEMISYNTHETIC HUMAN INSULINS. 43
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 40
Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia. 40
Il transfer genico del Vascular Endothelial Growth Factor (VEGF) stimola l’angiogenesi e la guarigione tissutale nel diabete sperimentale 39
[Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics]. 39
No evidence of increased fetal haemoglobin in an adult diabetic population 37
[Determination of serum fructosamine as a parameter of metabolic control in type 2 diabetes mellitus]. 37
Inflammatory markers in women with a recent history of gestational diabetes mellitus 36
MCP-1 and IP-10 serum levels in young patients with type 1 diabetes 36
LDH e isoenzimi intracellulari nella leucemia linfatica cronica 36
Leucemia mielomonocitica acuta e smouldering mieloma. contributo clinico 36
FATTORI PLASMATICI DELLA COAGULAZIONE E FUNZIONALITA’ PIASTRINICA IN DIABETICI VASCULOPATICI: EFFETTI DI UNA COMPLETA NORMALIZZAZIONE GLICEMICA OTTENUTA CON PANCREAS ARTIFICIALE. 34
High serum levels of soluble CD8 in insulin-dependent diabetes. 34
[Study of some serum lipid fractions (cholesterol, total lipids, triglycerides and lipoproteins) in aged subjects]. 33
[Some immunological aspects of old age: behavior of serum immunoglobulins and of circulating T lymphocytes (E rosettes)]. 29
Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis. 27
[Hourly profile of blood triglycerides in normal and atherosclerotic subjects before and after a low-fat diet]. 24
Multimodality imaging in chronic heart failure 20
Totale 2.337
Categoria #
all - tutte 8.436
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/2020352 48 19 0 12 2 23 51 47 5 74 71 0
2020/2021281 36 1 63 16 6 45 1 18 3 25 49 18
2021/2022308 2 37 6 8 9 4 22 12 7 69 39 93
2022/2023927 74 71 41 53 82 94 12 73 395 1 23 8
2023/2024213 13 45 9 26 21 92 2 3 1 1 0 0
Totale 2.337